Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 30 Sept 2026 for Royalty Pharma plc, €33k. Read the official filing
Filing timeline
BuySaleBonnie L. Bassler
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Bonnie L. Bassler: trading record in brief
Bonnie L. Bassler (board member) discloses dealings in 3 companies, chiefly Royalty Pharma plc, Regeneron Pharmaceuticals, Inc. and Cidara Therapeutics, Inc. In total, 55 filings cover trades dated from 25 June 2021 to 30 September 2026.
The open-market record consists of 1 sale worth €748k, with no purchase. Other entries cover 33 share grants and 20 option exercises.
The latest filing, published on 30 September 2026, reports a share grant of €33k in Royalty Pharma plc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Bonnie L. Bassler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations55 total
642 shares@ US$58.4055Class A Ordinary SharesSEC:0001683607-26-000016:0
689 sharesClass A Ordinary SharesSEC:0001683607-26-000014:0
4,545 shares0Class A Ordinary SharesSEC:0001683607-26-000012:0
815 shares@ US$45.9770.0001% mcap4.8% of flowClass A Ordinary SharesSEC:0001683607-26-000010:0
1,500 shares@ US$374.125.8% of flowCommon StockSEC:0001683607-26-000008:0
15 shares@ US$221.50100.0% of flowCommon StockSEC:0001683607-26-000006:0
155 shares0Common StockSEC:0001683607-26-000004:0
967 shares@ US$38.74184.7% of flowClass A Ordinary SharesSEC:0001683607-26-000002:0
760 shares@ US$371.403.0% of flowCommon StockSEC:0001683607-25-000006:0
1,047 shares@ US$35.78724.7% of flowClass A Ordinary SharesSEC:0001683607-25-000004:0
1,064 shares@ US$35.23954.7% of flowClass A Ordinary SharesSEC:0001802768-25-000075:0
7,614 shares0Class A Ordinary SharesSEC:0001802768-25-000045:0
1,141 shares@ US$32.86585.1% of flowClass A Ordinary SharesSEC:0001802768-25-000017:0
166 shares0Common StockSEC:0001968202-25-000002:0
1,503 shares@ US$24.94165.3% of flowClass A Ordinary SharesSEC:0001802768-25-000006:0
1,342 shares@ US$27.92494.9% of flowClass A Ordinary SharesSEC:0001802768-24-000055:0
756 shares@ US$371.403.1% of flowCommon StockSEC:0001968202-24-000123:0
756 shares@ US$371.403.1% of flowCommon StockSEC:0001883850-24-000041:0
1,399 shares@ US$26.79985.1% of flowClass A Ordinary SharesSEC:0001802768-24-000040:0
756 shares@ US$371.403.2% of flowCommon StockSEC:0001883850-24-000037:0
756 shares@ US$1,062.009.0% of flowCommon StockSEC:0001883850-24-000037:1
9,293 shares0Class A Ordinary SharesSEC:0001802768-24-000025:0
827 shares@ US$380.953.5% of flowCommon StockSEC:0001883850-24-000027:0
1,240 shares@ US$30.22835.1% of flowClass A Ordinary SharesSEC:0001802768-24-000016:0
854 shares@ US$391.923.7% of flowCommon StockSEC:0001968202-24-000074:0
25 of 55 declarations
